Cyagen Biomodels

Exhibitor

Founded in 2006, Cyagen is a global provider of genetically modified rodent models and advanced CRO solutions for biomedical research and drug development. With more than 900 employees and multiple research facilities covering 40,000 m², we serve researchers in more than 100 countries and support over 13,000 peer-reviewed publications – including in Cell, Nature, and Science.

Headquartered in Santa Clara, California, Cyagen also operates subsidiaries in Japan and China, along with major R&D and production centers in Guangzhou, Suzhou, and Gu'an (China). Leveraging its robust foundation in cell and animal model generation alongside powerful AI-driven discovery platforms, Cyagen offers scalable, reliable, and expert-backed one-stop solutions for accelerating both basic research and preclinical drug development.

To further advance translational research, Cyagen has developed several proprietary platforms:

HUGO-GT™ is a portfolio of genomic sequence humanized mouse models for translational research and drug discovery.

RDDC (Rare Disease Data Center) integrates genetic and disease databases, animal model resources with AI tools to benefit global biomedical research community.

HUGO-Ab™ provides next-generation fully human antibody mouse platforms for efficient therapeutic antibody discovery.

Abseek™ is our AI-powered platform for antibody screening, engineering, and design – streamlining antibody discovery from ideas to IND.

These innovations underscore our commitment to making research more efficient, accurate, and impactful.

website